SVLC — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Encellin develops next-generation therapies for patients with chronic unmet clinical needs, using technology originating from Dr.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Tejal Desai(Technology Expert, Founder)Ronald Martell(Strategic Advisor, Founder)inCrystal Nyitray(Executive Officer, Director, Promoter)inGrace Wei(Executive Officer, Director, Promoter)in
Board seatMaria del Consuelo Valverde· per SEC Form D · $9.9M raise · filed Dec 2023
Co-investorsEvolution VC PartnersHow Women InvestITERATIVEMetaplanetSand Hill AngelsBoxOne Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.